Ameriprise’s Aveanna Healthcare AVAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.87M Buy
917,829
+792,761
+634% +$5.59M ﹤0.01% 2220
2026
Q1
$805K Sell
125,068
-3,687
-3% -$28.5K ﹤0.01% 3400
2025
Q4
$1.05M Buy
128,755
+20,925
+19% +$189K ﹤0.01% 3306
2025
Q3
$956K Sell
107,830
-38,152
-26% -$241K ﹤0.01% 3385
2025
Q2
$763K Buy
145,982
+91,508
+168% +$465K ﹤0.01% 3375
2025
Q1
$295K Buy
54,474
+99
+0.2% +$467 ﹤0.01% 3678
2024
Q4
$248K Buy
+54,375
New +$278K ﹤0.01% 3790
2021
Q3
Sell
-13,202
Closed -$164K 3851
2021
Q2
$164K Buy
+13,202
New +$157K ﹤0.01% 3780

Other funds holding AVAH

Ameriprise's AVAH Position: Q2 2026 in Review

Ameriprise increased its Aveanna Healthcare (AVAH) stake by 634% in Q2 2026, buying an estimated $5.59M and bringing the position to 917,829 shares worth $7.87M. The position accounts for ﹤0.01% of the portfolio, ranked #2220.

Ameriprise first reported a position in AVAH in Q2 2021 and has held it in 8 quarters since. 215 funds tracked by Wall St. Rank hold AVAH as of Q2 2026.

  • Ameriprise held 917,829 shares of Aveanna Healthcare worth $7.87M as of Q2 2026.
  • Ameriprise bought 792,761 Aveanna Healthcare shares in Q2 2026, an estimated $5.59M.
  • Aveanna Healthcare made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #2220 holding.
  • Ameriprise first reported a position in Aveanna Healthcare in Q2 2021 and has held it in 8 quarters since.
  • 215 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.